Analyst Reco. Compugen Ltd.

Equities

CGEN

IL0010852080

Market Closed - Nasdaq Other stock markets 02:00:00 04/05/2024 am IST			5-day change	1st Jan Change
2.11 ^USD	-2.31%		+9.90%	+6.57%

08/03	Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating	MT
05/03	Transcript : Compugen Ltd., Q4 2023 Earnings Call, Mar 05, 2024

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Truist Securities Adjusts Price Target on Compugen to $5 From $4, Maintains Buy Rating	08/03	MT
Exchange-Traded Funds, US Equities Rise Pre-Bell Tuesday as Investors Continue to Hope for Federal Reserve Rate Cuts Soon	19/12	MT
Oppenheimer Adjusts Compugen's Price Target to $7 From $8, Maintains Outperform Rating	16/23/16	MT
Jefferies Downgrades Compugen to Underperform From Hold, Lowers Price Target to $0.50 from $2	08/23/08	MT
EF Hutton Initiates Compugen at Buy With $13 Price Target	05/23/05	MT
Oppenheimer Adjusts Compugen PT to $8 From $12, Updates Model to Reflect Evolving Development Strategy; Maintains Outperform Rating	15/22/15	MT
Truist Securities Adjusts Compugen's Price Target to $4 From $14, Reiterates Buy Rating	23/22/23	MT
JMP Securities Adjusts Price Target on Compugen to $4 From $8, Maintains Market Outperform Rating	08/22/08	MT
Oppenheimer Adjusts Compugen Price Target to $12 From $14, Maintains Outperform Rating	05/22/05	MT
Stifel Adjusts Compugen's Price Target to $5 From $12, Reiterates Buy Rating	05/22/05	MT
Jefferies Downgrades Compugen to Hold From Buy; Price Target is $2	05/22/05	MT
SVB Leerink Adjusts Compugen's Price Target to $9 from $16, Maintains Outperform Rating	25/22/25	MT
Oppenheimer Adjusts Compugen's Price Target to $14 From $17, Maintains Outperform Rating	25/22/25	MT
Oppenheimer Adjusts Compugen PT to $17 From $19, Maintains Outperform Rating	15/21/15	MT
COMPUGEN : SVB Leerink Adjusts Price Target on Compugen to $16 From $19, Maintains Outperform Rating	06/21/06	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer